Pharmaceutical Executive-09-01-2009

Pharmaceutical Executive
Features

September 01, 2009

Big Pharma navigates a regulatory minefield to reach social media consumers. It's anything but 'business as usual.'

Pharmaceutical Executive
Column

September 01, 2009

An open letter to Rep. Henry Waxman (D-CA)

Pharmaceutical Executive
Columns

September 01, 2009

With the emergence of user-generated content, marketers have to keep up on the buzz around their brands and categories on the Web.

Pharmaceutical Executive
Features

September 01, 2009

Bill Trombetta expands his annual guide to stellar performance with the "Heavenly 27."

Pharmaceutical Executive
Columns

September 01, 2009

Close the loop between the pros and the consumers by integrating patient-physician communications into pharma brand planning.

Pharmaceutical Executive
Washington Report

September 01, 2009

Pharma steps up development of new vaccines and treatments to combat Third World diseases

Pharmaceutical Executive
Columns

September 01, 2009

The prescription for better pharma marketing: Gain understanding of your physician-customers by leveraging key analytical insights.

Pharmaceutical Executive
From the Editor

September 01, 2009

Mastery of internal factors can mean the difference between thriving and failing in an environment where industry is a price taker, not a price setter.

Features
Pharmaceutical Executive

September 01, 2009

Brent Saunders, Schering-Plough's president of global consumer healthcare, talks growing role of OTC drugs in Pharma's future.

Pharmaceutical Executive
Features

September 01, 2009

The obesity pipeline, despite a hugely underserved market potentially worth $11 billion, is awfully thin.